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Importance 
Enterohemorrhagic Escherichia coli (EHEC) is a subset of pathogenic E. coli that 
can cause diarrhea or hemorrhagic colitis in humans. Hemorrhagic colitis 
occasionally progresses to hemolytic uremic syndrome (HUS), an important cause of 
acute renal failure in children and morbidity and mortality in adults. 
Enterohemorrhagic E. coli O157:H7 (EHEC O157:H7) has been known to cause these 
syndromes since the 1980s, but clinical cases and outbreaks caused by members of 
other EHEC serogroups are increasingly recognized. In some areas, non-O157 EHEC 
may account for a greater number of cases than EHEC O157:H7. In 2011, an unusual 
enteroaggregative E. coli (EAEC) with the serotype O104:H4 was responsible for a 
severe outbreak of hemorrhagic colitis and HUS in Europe. What all of the HUS-
associated E. coli seem to have in common is the ability to produce verotoxins, 
together with the ability to bind to and colonize human intestines. Because verotoxin 
genes can be transmitted between bacteria, additional E. coli pathotypes associated 
with HUS could also be discovered. 
Ruminants, particularly cattle and sheep, seem to be the maintenance hosts for 
EHEC O157:H7 and many other verotoxin-producing E. coli. Some, but not all, 
individual animals carry these organisms in the intestinal tract, and shed them in the 
feces. Members of other animal species are also infected occasionally. Most infected 
animals do not develop any clinical signs, although members of some non-O157 
serogroups may cause enteric disease in young animals, and EHEC O153 has been 
linked to a disease that resembles HUS in rabbits. Humans acquire EHEC by direct 
contact with animal carriers, their feces, infected people, and contaminated soil or 
water, or via the ingestion of underdone meat, other animal products, contaminated 
vegetables and fruit, and other foods. The infectious dose for people is very low, 
which increases the risk of disease. Animals do not seem to be reservoirs for 
enteroaggregative, verotoxin-producing E. coli, which are probably maintained in 
humans, but can also be acquired in food. 
Etiology 
Escherichia coli is a Gram negative rod (bacillus) in the family 
Enterobacteriaceae. Most E. coli are normal commensals found in the intestinal tract. 
Pathogenic strains of this organism are distinguished from normal flora by their 
possession of virulence factors such as exotoxins. Pathogenic E. coli can be classified 
into pathotypes by their virulence factors, together with the type of disease. The six 
pathotypes capable of producing gastrointestinal disease in humans are 
enteropathogenic E. coli (EPEC), enterotoxigenic E. coli (ETEC), enteroaggregative 
E. coli (EAEC), enteroinvasive E. coli (EIEC), diffusely adherent E. coli and 
enterohemorrhagic E. coli (EHEC). Some authors consider verotoxigenic E. coli 
(VTEC) to be the sixth pathotype, and EHEC to be a subset of VTEC. Most E. coli 
virulence factors are encoded on mobile elements (e.g., bacteriophages) than can 
move between organisms, and some organisms can have characteristics of more than 
one pathotype. A new category, enteroaggregative and enterohemorrhagic E. coli 
(EAHEC), was recently proposed. Other authors call these organisms 
"enteroaggregative, verotoxin-producing E. coli." 
Members of at least two pathotypes, EHEC and EAHEC, are capable of causing 
hemorrhagic colitis and hemolytic uremic syndrome in humans. (EAEC may cause 
bloody diarrhea, but it does not seem to be associated with HUS.) Both EHEC and 
EAHEC produce one or more toxins that are variously known as verotoxins, 
verocytotoxins or shiga toxins. There are two major families of verotoxins, Vtx1 and 
Vtx2, each of which can be further divided into subtypes (Vtx1a, 1c and 1d; Vtx2a to 
Vtx2e). An E. coli may produce Vtx1, Vtx2, or both. Some toxins seem to be 
associated with human illness more often than others. Vtx2, and especially Vtx2a, 
seems to be more common than Vtx1 in people with the most severe disease 
complications. EHEC and EAHEC are able to colonize and adhere to the human 
intestine, though in different ways. Most EHEC carry virulence factors (such as the 
intimin gene, eae) that give them the ability to cause attaching and effacing (A/E) 
lesions on human intestinal epithelium. A/E lesions are characterized by close 
 
Enterohemorrhagic Escherichia coli Infections 
Last Updated: November 2016 © 2009-2016 page 2 of 15 
bacterial attachment to the epithelial cell membrane and the 
destruction of microvilli at the site of adherence. EAHEC 
carry different virulence factors, and adhere to human 
intestinal cells by aggregative adherence fimbriae. The 
virulence genes associated with attachment (such as eae) 
are used, together with the presence of the verotoxin, to 
identify EHEC and EAHEC. Many VTEC are neither 
EHEC nor EAHEC. For example, some VTEC carry 
virulence factors that allow them to adhere well to the 
intestines of animals but do not colonize humans 
efficiently.  
Members of the other diarrhea-producing E. coli 
pathotypes might also be able to acquire verotoxins and 
cause HUS. No such organisms have yet been identified. 
Note on terminology 
The terminology for E. coli that cause HUS is currently 
inconsistent between sources. Some authors use the term 
EHEC for all VTEC that can cause hemorrhagic colitis and 
hemolytic uremic syndrome, while others prefer a strict 
definition based on the possession of specific virulence 
factors, and use the term "atypical EHEC" for similar 
organisms that cause HUS. Other groups use the term 
VTEC, while recognizing that only a subset of VTEC have 
been associated with human disease or HUS. There is also a 
proposal that all isolates should be labeled as VTEC, with 
an indication of the virulence factors involved in adhesion, 
instead of EHEC or EAHEC. For instance, organisms such 
as E. coli O157:H7 would be classified as AE-VTEC 
because they carry virulence factors for attaching and 
effacing lesions, and EAHEC such as O104:H4 would be 
considered Agg-VTEC.  
Serotypes involved 
E. coli are serotyped based on the O (somatic 
lipopolysaccharide), H (flagellar) and K (capsular) antigens. 
A number of serotypes are known to contain EHEC. Some 
well known organisms involved in human disease include 
E. coli O157:H7, E. coli O157:H- (also known as E. coli 
O157:NM, for "nonmotile"), and members of serogroups 
O26, O55, O91, O103, O111, O121 and O145. Additional 
serogroups that have been reported in human clinical cases 
are O45, O80, O104, O113, O117, O118, O128 and others. 
EHEC O153:H7 and O153:H- have been found in sick 
rabbits. Nearly all E. coli O157:H7 carry virulence factors 
associated with hemorrhagic colitis and HUS, and are 
considered to be EHEC; however, this is not necessarily the 
case for organisms in other serogroups. E. coli O157:H- is 
closely related to E. coli O157:H7, but it is not simply a 
nonmotile version of this organism; it has a distinctive 
combination of phenotypic and virulence features.   
EAHEC O104:H4 caused a severe outbreak in 
Germany in 2011. There are only rare descriptions of other 
EAHEC. For instance, one enteroaggregative E. coli 
O86:NM was isolated from a fatal case of HUS in Japan. 
Species Affected 
Ruminants, especially cattle, sheep, and possibly 
goats, are the major reservoirs for EHEC 0157:H7, but are 
not normally affected by this organism. It can also be 
found in asymptomatic bison and cervids (various deer, 
elk), and occasionally in other mammals including pigs, 
camelids, rabbits, horses, dogs, cats, zoo mammals (e.g., 
bears, large cats) and various free-living wild species 
(e.g., raccoons [Procyon lotor], opossums, rats), EHEC 
0157:H7 has sometimes been detected in the intestinal 
tracts of wild or domesticated birds, including, chickens, 
turkeys, geese, ostriches, pigeons, gulls, rooks, starlings 
and other species. In some instances, it is unclear whether 
a species acts as a maintenance host or if it is only a 
temporary carrier. For example, rabbits shedding EHEC 
O157:H7 have caused outbreaks in humans, but most 
infected rabbits were found near farms with infected 
cattle.  
A large number of non-O157 EHEC can be involved in 
human disease, and the reservoir hosts for these organisms 
are incompletely understood. VTEC are common in 
asymptomatic cattle and other ruminants; some of the 
organisms that have been found include EHEC O145, O45 
and O103, and VTEC O26, O113, O130 and O178. 
Members of serogroup O26 can also occur in other animals 
such as pigs, rabbits and chickens. EHEC O157:H- has 
been detected occasionally in cattle and other species, 
although initial studies suggested that this organism might 
not be animal-associated. Some wildlife, including cervids 
(deer, elk) and wild boar, have been found to carry various 
non-O157 EHEC, and might either act as reservoirs or 
acquire these organisms from domesticated animals. 
Domesticated rabbits appear to be reservoir hosts for EHEC 
O153:H- and O153:H7, and also seem to be susceptible to 
illness caused by these organisms.  
Animals are not thought to be reservoir hosts for 
enteroaggregative E. coli including EAHEC O104:H4. 
However, experimentally infected cattle can shed this 
organism, at least transiently. 
Zoonotic potential 
EHEC and EAHEC are important causes of illness in 
people. However, many VTEC found in animals, 
including some organisms that have the virulence factors 
for EHEC, have never been linked to human clinical 
cases. Why some organisms regularly cause illness in 
people, and others are found rarely or not at all, is still 
uncertain. 
Humans are the only known reservoir hosts for 
enteroaggregative E. coli and related species such as 
EAHEC O104:H4. 
Geographic Distribution 
EHEC 0157:H7 infections occur worldwide. However, 
the lineages of this organism are reported to differ between 
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regions, potentially influencing the incidence and severity 
of human disease.  
Non-O157 EHEC are also widely distributed. The 
importance of some EHEC serotypes may vary with the 
geographic area.  
EAHEC O104:H4 caused a major outbreak in Europe, 
but it has also been identified on other continents including 
Africa and Asia. 
Transmission 
EHEC and EAHEC are transmitted by the fecal–oral 
route. EHEC can spread between animals by direct contact 
or via water troughs, shared feed, contaminated pastures or 
other environmental sources. Birds and flies are potential 
vectors. In one experiment, EHEC O157:H7 was 
transmitted in aerosols when the distance between pigs was 
at least 10 feet. The organism was thought to have become 
aerosolized during high pressure washing of pens, but 
normal feeding and rooting behavior may have also 
contributed. 
Ruminants can shed EHEC O157:H7 transiently, 
intermittently or long-term, and animals that have stopped 
excreting it can be recolonized. This organism is known to 
colonize cattle at the terminal rectum (rectoanal junction); 
however, a recent study detected it along the entire length 
of the gastrointestinal tract and in the liver, suggesting that 
it might also persist at other sites such as the small intestine. 
Young ruminants are more likely to shed EHEC O157:H7 
than adults. A small proportion of the cattle in a herd, called 
super-shedders, excrete much higher levels of this organism 
than others. Initial studies suggested that super-shedding is 
a characteristic of particular individuals; however, some 
recent studies indicate that it might be a transient event that 
can occur in any animal. Super-shedding has also been 
identified in sheep. Animals that are not normal reservoir 
hosts for EHEC O157:H7 may become colonized for a time 
after contact with ruminants. Some animals may transiently 
shed organisms that were ingested from the environment 
but did not become established in the intestinal tract. 
Sources of human infection 
People mainly become infected with EHEC O157:H7 
by ingesting contaminated food and water, or during 
contact with animals (especially ruminants), feces and 
contaminated soil. The infectious dose for humans is 
estimated to be less than 100 organisms, and might be as 
few as 10. Foodborne outbreaks caused by EHEC O157:H7 
are often associated with undercooked or unpasteurized 
animal products, particularly ground beef, but also other 
meats and sausages (e.g., roast pork, salami, venison) and 
unpasteurized milk and cheese. Additional outbreaks have 
been linked to lettuce, spinach, various sprouts and other 
contaminated vegetables, unpasteurized cider, nuts and 
even pickled vegetables. Contaminated irrigation water is 
an important source of EHEC O157:H7 on vegetables. This 
organism can attach to a variety of edible plant material, 
although it seems to bind more readily to some fruits and 
vegetables than others. Depending on the environmental 
conditions, small numbers of bacteria left on washed 
vegetables may multiply significantly over several days. 
EHEC O157:H7 can be internalized in the tissues of some 
plants including lettuce, where it may not be susceptible to 
washing. Unexpected sources of EHEC, such as seafood 
(crab meat), raw prepackaged cookie dough and rice cakes, 
have also been reported. In some of these outbreaks, the 
organism was apparently introduced during food 
processing. EHEC O157:H7 can remain viable for long 
periods in many food products. It can survive for at least 
nine months in ground beef stored at -20°C (-4°F). It is 
relatively tolerant of acidity, and remains infectious for 
weeks to months in acidic foods such as mayonnaise, 
sausage, apple cider and cheddar at refrigeration 
temperatures. Salt might increase its resistance to 
inactivation in highly acidic foods such as pickles. It also 
resists drying. The epidemiology of non-O157 EHEC and 
EHEC O157:H- is incompletely understood. However, 
many of these outbreaks have also been associated with 
animal contact or foods (animal products or vegetables) or 
linked to water contaminated with feces. 
EHEC are usually eliminated by municipal water 
treatment, but these organisms may occur in private water 
supplies such as wells. Swimming in contaminated water, 
especially lakes and streams, has been associated with some 
human cases. Soil contamination has caused outbreaks at 
campgrounds and other sites, often when the site had been 
grazed earlier by livestock. Reported environmental 
survival times for E. coli range from a few days to nearly a 
year, and can be influenced by moisture, temperature, 
oxygen content, biological/ microbial components, and 
other factors. Survival in a specific environment is difficult 
to predict; however, one study found that EHEC O157:H7 
retained its infectivity for calves for approximately 6 
months in simulated water trough sediments. Most field 
studies have been conducted in temperate climates, and 
there is little or no knowledge about the survival of these 
organisms in tropical regions.  
Person-to-person transmission of EHEC and EAHEC 
can contribute to disease spread during outbreaks, via the 
fecal-oral route. Young children tend to shed these 
organisms longer than adults. Humans do not appear to be a 
significant reservoir for EHEC O157:H7. Most people 
excrete this organism for approximately 7 to 9 days; a 
minority can shed it for a few weeks and up to several 
months after the onset of symptoms. EAHEC, which is 
probably maintained in humans, seems to persist longer. In 
a large German outbreak, most people stopped shedding 
EAHEC O104:H4 by 1 month; however, this organism was 
still found for several months in the feces of some 
individuals, and for a year in a few people. 
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Disinfection 
E. coli can be killed by numerous disinfectants 
including 1% sodium hypochlorite, 70% ethanol, phenolic 
or iodine–based disinfectants, glutaraldehyde and 
formaldehyde. This organism can also be inactivated by 
moist heat (121°C [250°F] for at least 15 min) or dry heat 
(160–170°C [320-338°F] for at least 1 hour). Foods such as 
ground beef can be made safe by cooking them to a 
minimum temperature of 160°F/ 71°C. Ionizing radiation or 
chemical treatment with various substances, such as sodium 
hypochlorite or acetic acid, may reduce or eliminate 
bacteria on produce. 
Bacteria in biofilms are more difficult to destroy, and 
longer treatment times are usually necessary. Heat, steam 
and other physical means combined with disinfectants can 
be more effective than disinfectants alone. 
Infections in Animals 
Clinical Signs 
A few members of some non-O157 EHEC serogroups 
(e.g., O26, O111, O118, O5) may cause diarrhea and other 
gastrointestinal signs in young (< 3-month-old) ruminants. 
However, older ruminants are unaffected by these 
organisms, and EHEC O157:H7 is normally carried in the 
intestinal tract without clinical signs. In experiments, the 
latter organism did not seem to cause disease in calves older 
than one week of age, although some neonatal (< 2-day-old) 
calves developed bloody or mucoid diarrhea, and some of 
these animals died.. A recent outbreak of fatal 
meningoencephalitis and septicemia in one-month-old goats 
was caused by VTEC O157:H7.  
EHEC O157:H7 does not appear to be an important 
pathogen in naturally-infected rabbits or piglets, although 
gnotobiotic and suckling piglets and young (5-10 day-old) 
rabbits are used as experimental models for human disease. 
Hemorrhagic or watery diarrhea occurs in the rabbits, and 
diarrhea and CNS signs in the piglets. However, EHEC 
O153:H- was linked to an outbreak of hemorrhagic diarrhea 
and an illness resembling HUS in domesticated rabbits. 
Rabbits that were experimentally infected with this 
organism also developed hemorrhagic diarrhea with 
lethargy, inappetence, dehydration and weight loss. VTEC 
that produce Vtx2e cause edema disease in pigs, but the 
adhesion factors involved in this disease (fimbrial adhesin, 
F18) are not the same as those causing EHEC-associated 
illness in humans, and Vtx2e seems to be rare in people 
with HUS.  
Dogs that were experimentally inoculated with EHEC 
O157:H7 developed transient acute diarrhea with decreased 
appetite and vomiting, but recovered spontaneously without 
complications in 1-2 days. In the same experiment, dogs 
inoculated with an unspecified non-O157 EHEC (from a 
severe human clinical case) developed severe disease, with 
diarrhea and vomiting followed by lethargy and 
inappetence, dehydration and dramatic weight loss. These 
dogs also had neurological signs including seizures, 
cerebral infarction, blindness and coma, and died 5-6 days 
after the onset of clinical signs.  
A few inconclusive reports suggest that EHEC might 
occasionally affect other species. EHEC O157:H7 was 
recently isolated from a few naturally-infected dromedaries 
(Camelus dromedarius) with hemorrhagic diarrhea, but 
there was no further information about the disease or its 
severity, or whether other causes were ruled out. An 
unspecified EHEC was detected in two nonhuman primates 
during an outbreak of diarrhea in captive cynomolgus and 
rhesus macaques. One animal was coinfected with 
Campylobacter, and the other with Helicobacter, and 
enteroinvasive E. coli was found in other sick macaques 
during this outbreak.  
Healthy mice and ferrets do not seem to be susceptible 
to EHEC; however, ferrets pretreated with antibiotics 
before experimental infection developed weight loss 
without diarrhea. 
Post Mortem Lesions      Click to view images 
EHEC lesions in clinically affected ruminants are 
usually characterized by inflammation of the intestinal 
mucosa, and are generally limited to the large intestine. In 
some cases, a fibrinohemorrhagic exudate is present.  
In rabbits experimentally infected with EHEC O153, 
the cecum and/or proximal colon were edematous and 
thickened, and the serosal surfaces had petechial or 
ecchymotic hemorrhages. Pale kidneys were also reported. 
Dogs infected with EHEC O157:H7 had no significant 
gross lesions. In dogs inoculated with a non-O157 EHEC 
strain, the primary cause of death was microvascular 
thrombosis leading to kidney failure and multiple organ 
failure. This syndrome resembled HUS. In these dogs, 
inflammation and edema occurred in the small and large 
intestines. The kidneys were pale, with a few petechiae on 
the serosal surface. The liver was enlarged, with 
inflammation and necrotic lesions. 
Diagnostic Tests 
Carrier animals are usually detected by finding EHEC 
in fecal samples, which are either freshly voided or taken 
directly from the animal. Rectoanal mucosal swabs are 
useful for some purposes, but seem to detect fewer infected 
animals. Repeated sampling, as well as sampling more 
animals, increases the chance of detection. EHEC can also 
be found in other locations, such as hides or dust, and 
additional methods (e.g., liquid absorbing overshoes) have 
been suggested for sampling entire pens or groups of 
animals. Animals are not sampled routinely for EAHEC. 
EHEC can be difficult to identify in animals. They are 
a minor population in the fecal flora, and they closely 
resemble commensal E. coli except in verotoxin production. 
There is no single technique that can be used to isolate all 
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EHEC and EAHEC. Many diagnostic laboratories can 
identify VTEC O157:H7. Selective and differential media 
have been developed for this organism, based on its lack of 
β-glucuronidase activity and the inability of most strains to 
rapidly ferment sorbitol (e.g., MacConkey agar containing 
1% sorbitol [SMAC], hemorrhagic colitis agar, or 
commercial chromogenic agars). Because other strains of E. 
coli, as well as other bacteria, can also grow on these 
media, prior enrichment for E. coli O157 aids detection. 
Samples may be cultured in selective or nonselective liquid 
enrichment medium, or members of serogroup O157 can be 
concentrated on magnetic beads coated with an antibody to 
O157 (immunomagnetic separation [IMS]) before plating. 
Colonies suspected to be EHEC O157:H7 are confirmed to 
be E. coli with biochemical tests, and shown to have both 
the O157 somatic antigen and the H7 flagellar antigen with 
immunoassays or other techniques. While both verotoxin 
and EHEC-associated-genes must be confirmed to prove 
that an E. coli belongs to the EHEC pathotype, nearly all 
VTEC O157:H7 do carry these genes. Phage typing and 
various DNA-based methods, such as pulsed field gel 
electrophoresis (PFGE) or multiple-locus variable-number 
tandem-repeat analysis (MLVA), can subtype EHEC 
O157:H7 for epidemiology. These tests are generally done 
by reference laboratories. The techniques used to identify 
EHEC O157:H7 can miss atypical strains of this organism, 
including rare sorbitol-fermenting isolates.  
The selective methods used to detect EHEC O157:H7 
do not identify EHEC O157:H– or non-O157 EHEC, 
which are biochemically similar to other E. coli and do 
ferment sorbitol. Selective media and isolation techniques 
have been developed for only a few of these organisms. 
IMS beads are commercially available for concentrating 
some common EHEC serogroups including O26, O103, 
O111 and O145, and at least one selective medium (CT-
RMAC) can be used to isolate and identify EHEC O26. 
Non-O157 VTEC are not necessarily EHEC or EAHEC, 
and must be tested for the virulence factors carried by 
these organisms. Because these techniques are labor-
intensive and not widely available, non-O157 EHEC and 
EAHEC are generally detected by their verotoxin-
production, and sent to a reference laboratory for further 
identification. Verotoxins or their genes can be identified 
with immunoassays, PCR or other tests such as Vero cell 
(or HeLa) toxicity assays.   
Rapid immunological and nucleic acid-based tests that 
detect O and H antigens, verotoxin or various genes 
associated with EHEC are used with human clinical 
samples (see below) or food samples, but some kits 
validated for these purposes may lack sensitivity when 
testing fecal samples from animals. 
Although cattle can produce antibodies to O157, 
serology is not used routinely in animals to diagnose 
infections with VTEC or EHEC. 
 
Control 
Disease reporting 
Veterinarians should follow their national and/or local 
guidelines (if any) for screening and/or reporting EHEC, 
EAHEC and other organisms of concern. Some countries 
have also defined specific EHEC, including both O157:H7 
and some common non-O157 EHEC, as of regulatory 
concern in food products.  
Prevention 
Because EHEC are not usually significant pathogens in 
animals, preventive measures are mainly intended to reduce 
carriage for the benefit of humans. How best to accomplish 
this is still unclear. Identifying and targeting super-shedders 
has been proposed as a particularly effective means of 
control; however, the effects of such measures and methods 
to identify supershedding animals are still debated. Vaccines 
against EHEC O157:H7 may reduce shedding, and have 
received full or conditional approval in some countries 
including the U.S. and Canada, but are not in wide use. Other 
proposed interventions include the application of 
disinfectants (e.g., chlorhexidine), various antimicrobials or 
bacteriophages to the terminal rectum; the use of probiotics 
that would preferentially colonize the gastrointestinal tract; 
dietary manipulations; reductions in animal density in 
feedlots to decrease transmission rates; and hygiene/ 
management measures such as the provision of dry bedding, 
frequent cleaning of water troughs and the grouping of 
animals in the same cohorts through each stage of growth. 
These interventions are generally still in the research stage, 
although some appear promising. In addition, animals should 
not be allowed to graze pastures for a period after effluent 
that may contain EHEC has been applied. 
Management practices to decrease EHEC in the 
environment include the storage of effluents on a cement 
floor for 3 months or longer before discharge, and the 
collection of all liquids in a trap to minimize leaching of 
liquid manure into groundwater. Some EHEC may remain 
after long-term storage. Composting manure before use as a 
fertilizer may reduce transmission from this source; 
however, the survival of the organism varies with the size 
and composition of the compost heap, the temperature 
attained, and the initial concentration of EHEC. Other 
biological processes (aerobic and anaerobic digestion), heat 
drying, and/or chemical treatments have been proposed to 
sanitize farm effluents before discharge into the 
environment. Soil treatments such as lime or solarization 
are also being investigated as a means to destroy these 
organisms more rapidly in contaminated soil.  
Colonization seems to be uncommon in companion 
animals, and methods to eliminate EHEC from these 
animals have not been established. However, oral 
autovaccination with a heat-inactivated EHEC strain 
(O145:H–) stopped the shedding of this organism in a 
persistently infected cat.  
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Morbidity and Mortality 
EHEC O157:H7 seems to be most common in 
ruminants. Surveys have found this organism in < 1% to 
67% of cattle, depending on the country, type of herd 
studied, detection method and other factors, with most 
larger studies indicating an overall prevalence < 15%. In the 
E.U., VTEC O157 was detected in 0.2-2.3% of cattle 
between 2007 and 2011. Animals in feedlots appear more 
likely to shed EHEC O157:H7 than animals on pasture or 
dairy cattle. Young cattle are more likely to be infected than 
older animals, although this organism seems to be 
uncommon in preweaning calves. Its prevalence in sheep 
and goats appears to be similar or lower than in cattle. In 
cattle, EHEC O157:H7 infections seem to be influenced by 
the season, and many studies have found that this organism 
is more common from spring to early autumn. However, a 
few studies reported other patterns or did not find that 
shedding was seasonal, Management factors or climatic 
factors (e.g., warm climates) might account for these 
differences. Seasonality has also been reported in sheep. 
Information about other EHEC is more limited; however, 
VTEC were detected in 2-13.5 % of cattle in the E.U. 
between 2007 and 2011. VTEC isolation rates among cattle 
in individual European countries ranged from 0% to 54% in 
these studies. Seasonal prevalences of some EHEC 
serotypes may differ from that of O157:H7. 
EHEC O157:H7 has been found in some herds of pigs, 
but it seems to be uncommon in this species. One U.S. 
study found a high prevalence (47%) of EHEC O157:H7 in 
bison, but only 2% of camelids appeared to carry this 
organism in a limited, opportunistic survey in the U.K. Its 
prevalence in deer is reported to be < 3% in some surveys. 
While EHEC O157:H7 has been found occasionally in dogs 
and cats, especially on farms, it was rarely detected in a few 
surveys of pets. Limited evidence also suggests that few 
horses or chickens are carriers, especially when they are not 
housed near ruminants. The prevalence might be higher in 
turkeys. EHEC O157:H7 has been detected in rabbits, and 
EHEC O153 might be relatively common in this species. In 
one study, 25% of Dutch belted rabbits and 9% of New 
Zealand white rabbits from one commercial source had 
EHEC O153:H- or O153:H7 in their feces. . 
Morbidity in adult ruminants appears to be negligible 
or absent, although young animals may be affected by some 
serogroups. Deaths have been reported in some 
experimentally infected animals including some calves, 
dogs inoculated with a non-O157 EHEC from a human 
clinical case, and rabbits inoculated with EHEC O153.  
Infections in Humans 
Incubation Period 
The incubation period for EHEC O157:H7-associated 
illness ranges from one to 16 days, but most infections 
become apparent after 3-4 days. The incubation period for 
EAHEC O104:H4 seems to be longer, with a median 
incubation period of 8-9 days. 
Clinical Signs 
Humans can be infected asymptomatically with EHEC 
or EAHEC, or they may develop watery diarrhea, 
hemorrhagic colitis and/ or hemolytic uremic syndrome. 
Most symptomatic cases begin with diarrhea. Some resolve 
without treatment, but others progress to hemorrhagic 
colitis within a few days. Hemorrhagic colitis is 
characterized by diarrhea with profuse, visible blood, 
accompanied by abdominal tenderness, and in many cases, 
by severe abdominal cramps. Nausea, vomiting and 
dehydration may also be seen. Some patients have a low–
grade fever; however, fever often resolves by the time 
hemorrhagic colitis appears, and can be absent. Many cases 
of hemorrhagic colitis are self–limiting and resolve in 
approximately a week. Complications in severe cases may 
include intestinal necrosis, perforation or the development 
of colonic strictures.  
Hemolytic uremic syndrome occurs in a minority of 
patients with hemorrhagic colitis. This syndrome is most 
common in children, the elderly and those who are 
immunocompromised. It usually develops about a week 
after the diarrhea begins, when the patient is improving, 
but there are occasional cases without prodromal diarrhea. 
HUS is characterized by acute kidney injury, hemolytic 
anemia and thrombocytopenia. The relative importance of 
these signs varies. Some patients with HUS have 
hemolytic anemia and/or thrombocytopenia with little or 
no renal disease, while others have significant kidney 
disease but no thrombocytopenia and/or minimal 
hemolysis. Extrarenal signs can include CNS involvement, 
ranging from lethargy, irritability and seizures to paresis, 
stroke, cerebral edema or coma; respiratory syndromes 
(e.g., pleural effusion, fluid overload, adult respiratory 
distress syndrome); elevation of pancreatic enzymes or 
pancreatitis; and uncommon complications such as 
rhabdomyolysis, bacteremia, deep abscesses or 
myocardial involvement. The form of HUS usually seen in 
adults, particularly the elderly, is sometimes called 
thrombotic thrombocytopenic purpura (TTP). In TTP, 
there is typically less kidney damage than in children, but 
neurological signs are more common. Deaths occur most 
often in patients with serious extrarenal disease, such as 
severe CNS signs. Long-term renal complications of 
varying severity can be seen in some patients, although 
many or most children recover from HUS without 
permanent damage. There may also be residual extrarenal 
problems such as transient or permanent insulin-dependent 
diabetes mellitus, pancreatic insufficiency, or neurological 
defects such as poor fine-motor coordination.  
In rare cases, EHEC including EHEC OH157:H7 have 
caused urinary tract infections, with or without diarrhea 
and/or HUS.  
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Diagnostic Tests 
Because humans do not normally carry EHEC, clinical 
cases can be diagnosed by finding these organisms in fecal 
samples. Samples should be collected as soon as possible 
after the onset of diarrhea, as these bacteria may be cleared 
after a week. There is relatively little information yet about 
EAHEC; however, some people seem to shed EAHEC 
O104:H4 subclinically for a prolonged period after 
recovery.  
The techniques to identify EHEC and EAHEC are 
similar to those used in animals. Many diagnostic 
laboratories can identify EHEC O157:H7. The U.S. Centers 
for Disease Control and Prevention (CDC) recommends 
that all samples also be tested for verotoxins and/or their 
genes, to determine whether they might contain non-O157 
EHEC or EAHEC. Samples that test positive are generally 
sent to a reference laboratory for further testing. 
Immunological and nucleic acid-based rapid tests that 
detect O and H antigens, verotoxin or various genes 
associated with EHEC and EAHEC can be used for 
presumptive diagnosis. These tests may include dipstick 
and membrane technologies, agglutination tests, microplate 
assays, colony immunoblotting, PCR, immunofluorescence 
and ELISAs. Fecal samples can be tested directly with 
some tests, but sensitivity is improved by testing cultures or 
enrichment broths. EHEC may occasionally lose the 
verotoxin by the time HUS develops. The results from rapid 
tests are usually confirmed by isolating the organism. 
Organisms confirmed to be EHEC or EAHEC can be 
subtyped at a reference laboratory, to aid in finding the 
source of an outbreak. Potential food and environmental 
sources may also be tested.  
Serology is valuable in humans, particularly later in the 
course of the disease when EHEC are difficult to find. 
Diagnostic tests that detect antibodies to some serogroups, 
including EHEC O157:H7, are available. In some cases, 
antibodies may persist for months after infection. Cross-
reactivity with other bacteria is possible.  
Treatment 
Treatment of EHEC- or EAHEC-associated 
hemorrhagic colitis is supportive, with measures such as 
fluids and a bland diet. Antibiotics do not seem to reduce 
symptoms, prevent complications or decrease shedding, and 
they appear to increase the risk of HUS. While the effects 
of specific antibiotics are still incompletely understood, 
current recommendations suggest that these drugs should be 
avoided if possible (although there may be some situations, 
such as complications, where this is not feasible). The use 
of antimotility agents in hemorrhagic colitis also seems to 
increase the risk for developing HUS. There are no 
established treatments to neutralize or remove verotoxins, 
although experimental treatments have been suggested or 
used. For instance, one report suggested that daily intestinal 
lavage, combined with intravenous rehydration, may reduce 
the risk of HUS.  
Patients with HUS may require intensive supportive 
care including treatment of kidney dysfunction, ﬂuid 
management, treatment of arterial hypertension, and other 
measures such as ventilatory support if required. Additional 
treatments are under investigation. Patients who develop 
irreversible kidney failure may need a kidney transplant.  
Azithromycin appeared to be useful in decolonizing 
patients who had recovered from illnesses caused by 
EAHEC O104:H4 but continued to shed this organism 
long-term.  
Prevention 
Frequent hand washing, especially before eating or 
preparing food, and good hygiene can decrease the risk of 
acquiring EHEC from animals and their environment. Hand 
washing facilities should be available in petting zoos and 
other areas where the public may contact livestock, and 
eating and drinking should be discouraged at these sites. To 
protect children and other household members, people who 
work with animals should keep their work clothing, 
including shoes, away from the main living areas and 
launder these items separately. Two children apparently 
became infected with EHEC O157:H7 after contact with 
bird (rook) feces, possibly via their father’s soiled work 
shoes or contaminated overalls. After a number of 
outbreaks associated with camping in the U.K., the Scottish 
E. coli O157 Task Force has recommended that ruminants 
not be grazed on land for at least 3 weeks before camping 
begins.  
Techniques to reduce microbial contamination during 
slaughter and meat processing can reduce the risks from 
animal products, though they are unlikely to eliminate these 
organisms completely. Some countries have established 
screening and control programs for EHEC O157:H7 and 
some other VTEC in meat. Meat should be cooked 
thoroughly to kill E. coli, and consumers should practice 
good hygiene to prevent cross-contamination via hands, 
cutting boards and other objects. Unpasteurized milk or 
other dairy products and unpasteurized juices can also 
contain EHEC, and are best avoided.. 
Livestock wastes and contaminated water should be 
kept away from watercourses or vegetable crops that will be 
eaten raw by humans. Current U.S. guidelines suggest a 
minimum of 120 m (400 ft) between feedlots and crops of 
leafy green vegetables; however, one experiment detected 
contamination on vegetable plots 180 m from a feedlot. The 
fresh produce industry may use various post-harvest 
measures, in addition to washing, to decrease 
contamination. A dilute chlorine solution may be used to 
reduce bacterial numbers; however, one study found that a 
vinegar wash (6% acetic acid) was more effective. 
Vegetables (including prewashed, bagged vegetables) 
should also be washed under running water before use. 
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Under some environmental conditions, populations of 
bacteria in washed produce can build up again after a few 
days. Organisms carried internally in plant tissues are 
difficult to destroy except by irradiation or cooking.  
Contamination of public water supplies is prevented by 
standard water treatment procedures. Livestock-should be 
kept away from private water supplies. Microbiological 
testing can also be considered. People should try to avoid 
swallowing water when swimming or playing in lakes, 
ponds and streams. 
Good hygiene, careful hand-washing and proper 
disposal of infectious feces can reduce person-to-person 
transmission. Thorough hand washing is especially 
important after changing diapers, after using the toilet, and 
before eating or preparing food. In some areas, regulations 
may prohibit infected children from attending daycare or 
school until they are no longer shedding organisms. Some 
authors suggest that isolating infected children from their 
young siblings or other young household members can 
significantly decrease the risk of secondary spread.  
Morbidity and Mortality 
Clinical cases caused by EHEC and EAHEC can occur 
sporadically or in outbreaks. For EHEC O157:H7, the 
estimated annual incidence ranges from < 0.5 to > 50 cases 
per 100,000 population in various countries. In many areas, 
the number of cases caused by non-O157 EHEC is thought 
to be at least as high, and sometimes higher. Young 
children are affected most often; however, there have been 
incidents, such as the 2011 EAHEC O104:H4 outbreak in 
Germany, where most cases occurred in adults (possibly 
because adults were more likely to eat the contaminated 
food). EHEC O157:H7 infections tend to occur during the 
warmer months in temperate climates, probably due to 
seasonal shedding patterns in animals and/or other factors 
such as eating undercooked meat at summer barbecues. 
Other EHEC do not necessarily follow the same seasonal 
pattern, and might peak at other times. Nursery schools are 
common sites of non-O157 EHEC outbreaks in some 
countries, and these outbreaks seem to be propagated by 
person-to-person transmission.  
How many people are infected without clinical signs is 
uncertain. Various investigations have found that up to 5-
9% of infections were asymptomatic, but some 
subclinically infected people were probably missed. In 
Japan, active surveillance suggests that 35% of EHEC 
infections may be subclinical, with the highest prevalence 
of these infections in healthy adults. Some developing 
countries have reported few or no cases of EHEC-
associated HUS, although EHEC O157:H7 and other 
pathogenic organisms have been detected. The reasons for 
this are still unclear, but limited diagnosis and surveillance, 
competition with other microorganisms on foodstuffs, 
and/or cross-reactive immunity from other virulent E. coli 
have been suggested as possibilities.  
What proportion of infected people develop 
uncomplicated diarrhea, hemorrhagic colitis and HUS is 
incompletely understood, but may differ between 
organisms. EHEC O157:H7 is widely considered to be 
one of the most virulent organisms, but members of other 
serotypes (e.g., EHEC O80:H2, EHEC O111, EAHEC 
O104:H4) have also caused severe outbreaks. In European 
surveillance, approximately twice as many patients had 
diarrhea as hemorrhagic colitis between 2007 and 2010; 
however, some cases may not have been seen by a 
physician, especially when they involved uncomplicated, 
non-bloody diarrhea. Approximately 5-10% of patients 
with hemorrhagic colitis are estimated to develop HUS, 
but higher percentages (up to 40%) have been reported in 
some outbreaks,  
In clinical cases, the mortality rate varies with the 
syndrome. Hemorrhagic colitis alone is usually self–
limiting, although deaths can occur. Complications and 
fatalities are particularly common among children, the 
elderly, and those who are immunosuppressed or have 
debilitating illnesses. EHEC-associated HUS/ TTP is 
estimated to be fatal in 1-10% of children and up to 50% 
of the elderly. In European surveillance, the case fatality 
rate in all reported EHEC infections was < 0.5%. In the 
EAHEC O104:H4 outbreak, the case fatality rate was 
1.4% in all patients with clinical signs, and approximately 
6% in patients with HUS/ TTP. 
Internet Resources 
Centers for Disease Control and Prevention (CDC). 
Escherichia coli 
https://www.cdc.gov/ecoli/ 
European Food Safety Authority. Scientific Opinion on 
VTEC-seropathotype and scientific criteria regarding 
pathogenicity assessment 
https://www.efsa.europa.eu/en/efsajournal/pub/3138 
Public Health Agency of Canada. Pathogen Safety Data 
Sheets and Risk Assessment 
http://www.phac-aspc.gc.ca/lab-bio/res/psds-ftss/index-
eng.php 
The Institute of Food Technologists 
http://www.ift.org  
The Merck Manual of Diagnosis and Therapy 
http://www.merckmanuals.com/professional 
USDA. FSIS. Escherichia coli O157:H7 and other Shiga 
toxin-producing E. coli (STEC) 
https://www.fsis.usda.gov/wps/portal/fsis/topics/food-
safety-education/get-answers/food-safety-fact-
sheets/foodborne-illness-and-disease/escherichia-coli-
o157h7/CT_Index 
World Organization for Animal Health (OIE) 
http://www.oie.int  
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OIE Manual of Diagnostic Tests and Vaccines for 
Terrestrial Animals 
http://www.oie.int/international-standard-
setting/terrestrial-manual/access-online/ 
OIE Terrestrial Animal Health Code 
http://www.oie.int/international-standard-
setting/terrestrial-code/access-online/  
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